I think a vaccine strategy that would have resulted in enough vaccines to vaccinate everyone at the end of 2020 would have been benefitial to a vaccine strategy that helps Moderna and BioNTech gather more experience with their technology platforms.
I’m not arguing that giving Moderna experience with their technology platform isn’t useful but it’s not worth the delay in vaccination over using technology that can be more easily scalled up.
I think a vaccine strategy that would have resulted in enough vaccines to vaccinate everyone at the end of 2020 would have been benefitial to a vaccine strategy that helps Moderna and BioNTech gather more experience with their technology platforms.
I’m not arguing that giving Moderna experience with their technology platform isn’t useful but it’s not worth the delay in vaccination over using technology that can be more easily scalled up.